[1]
D. Paoletti and S. Giorgi, “Bevacizumab in the treatment of metastatic colorectal cancer: the RFOM in the experience of the A.O. University of Siena”, Grhta, vol. 2, no. 1, pp. 61–62, Mar. 2015.